DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000HD59A16

Real-time Boerse Frankfurt Warrants 10:30:42 2024-07-04 EDT
3.13 EUR -1.57% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+2.25%
1 month+31.95%
Date Price Change
24-07-04 3.13 -1.57%
24-07-03 3.18 +0.63%
24-07-02 3.16 +1.94%
24-07-01 3.1 -0.32%
24-06-28 3.11 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 10:30 am

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD59A1
ISINDE000HD59A16
Date issued 2024-05-03
Strike 44
Maturity 2024-12-18 (167 Days)
Parity 1 : 1
Emission price 2.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.22
Lowest since issue 2.12
Spread 0.02
Spread %0.63%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.61 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.25%
Consensus